News & Updates

Show Multimedia Only
Prexasertib works in select patients with recurrent ovarian cancer

Prexasertib works in select patients with recurrent ovarian cancer

14 Oct 2022

CHK1 inhibition with prexasertib appears to have durable activity in some patients with recurrent ovarian cancer regardless of clinical characteristics, BRCA status, or prior therapies, according to the results of a phase II trial.

14 Oct 2022
Early noninferior to delayed NOAC initiation after stroke in AF patients

Early noninferior to delayed NOAC initiation after stroke in AF patients

13 Oct 2022

Early initiation of nonvitamin K antagonist oral anticoagulants (NOACs) after acute ischaemic stroke in patients with atrial fibrillation (AF) appears to yield similar outcomes when compared with delayed initiation, as shown in the results of the TIMING* study.

13 Oct 2022